Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Psiquiatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind Parallel Group Placebo-Controlled Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressants in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
INTERVENTIONAL
Inicio: 1 de sept de 2010
ID: NCT01197508
Completado
Fase 4
ClinicalTrials.gov
Predicting Response to Risperidone Treatment Through Identification of Early-onset of Antipsychotic Drug Action in Schizophrenia.
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00337662
Completado
Fase 3
ClinicalTrials.gov
An International, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Controlled Study of the Efficacy and Safety of Sustained-Release Quetiapine Fumarate (Seroquel SR™ ) in the Treatment of Generalized Anxiety Disorder (SILVER)
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00322595
Completado
Fase 3
ClinicalTrials.gov
An Eight-week, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Saredutant 100 mg Once Daily in Combination With Escitalopram 10 mg Once Daily in Patients With Major Depressive Disorder
INTERVENTIONAL
Inicio: 1 de sept de 2007
ID: NCT00531622
Completado
Fase 4
ClinicalTrials.gov
Duloxetine Versus Placebo in the Treatment of Elderly Patients With Generalized Anxiety Disorder
INTERVENTIONAL
Inicio: 1 de oct de 2010
ID: NCT01118780
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-label Study Comparing the Effects of Olanzapine Pamoate Depot With Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
INTERVENTIONAL
Inicio: 1 de abr de 2006
ID: NCT00320489
Completado
Fase 3
ClinicalTrials.gov
Single-arm, Open-label Extension to a Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation
INTERVENTIONAL
Inicio: 19 de sept de 2019
ID: NCT04072575
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).
INTERVENTIONAL
Inicio: 1 de jul de 2011
ID: NCT01369095
Completado
Fase 3
ClinicalTrials.gov
An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
INTERVENTIONAL
Inicio: 30 de sept de 2015
ID: NCT02497287
Completado
Fase 3
ClinicalTrials.gov
A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00731549
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01072630
Terminado
Fase 2
ClinicalTrials.gov
Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00412620
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared With Quetiapine Extended-Release in Adult and Elderly Participants With Treatment-Resistant Major Depressive Disorder Who Are Continuing a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor
INTERVENTIONAL
Inicio: 21 de ago de 2020
ID: NCT04338321
Completado
Fase 4
ClinicalTrials.gov
Prospective Randomised Double Blind Trial of Ketiapine and Olanzapine Comparative Efficacy for Fast Sedation of Severely Agitated Patients in Emergency Psychiatric Ward
INTERVENTIONAL
Inicio: 1 de ene de 2015
ID: NCT03216941
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel, 26-Week, Phase 3 Study of 2 Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo as an Adjunctive Pro-cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01716975
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01305408
Completado
ClinicalTrials.gov
Evaluation on the Effect on Cognition and Emotional Exhaustion With a Change of Long Night Shift System Versus Reduced Night Shift in Residents of Internal Medicine
OBSERVATIONAL
Inicio: 8 de ago de 2019
ID: NCT04053556
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel, 26-Week, Phase 3 Study of 2 Doses of an Alpha-7 Nicotinic Acetylcholine Receptor Agonist (EVP-6124) or Placebo as an Adjunctive Pro-cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01714661
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)
INTERVENTIONAL
Inicio: 18 de jul de 2025
ID: NCT06929273
Completado
Fase 4
ClinicalTrials.gov
Open-label Long-Term Extension Study for Participants With Treatment-Resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment From Study 54135419TRD3013
INTERVENTIONAL
Inicio: 26 de abr de 2021
ID: NCT04829318
Anterior
1
...
3
4
5
...
434
Siguiente
Filtros